Opinion
A time for clarity
Pharmacy needs clarity and unity if it is to have a strategic approach to codeine rescheduling, says Rick Samimi The codeine rescheduling issue has been challenging for community pharmacy. Despite …
Prepare now for life after OTC codeine
It’s time to talk to patients about protecting them from opioid-related harms, writes Debbie Rigby From 1 February 2018 all codeine-based medications will become prescription-only. Low-dose codeine is currently used …
Harm minimisation from the past to the future
Whether helping smokers or those who use illicit drugs, pharmacists are at the coalface of harm minimisation, writes Angelo Pricolo Pharmacists are the most important and effective health professional in …
Reflections on rural Australia
Pharmacy Student of the Year Jessica Bailey shares some thoughts on her recent pharmacy placement in outback NSW Jessica Bailey is a pharmacy student at Monash University, currently finishing her …
Embrace the detours
How you handle the unexpected can have a big payoff, writes Karen Brown The path to business success is a road full of obstacles and detours. How you navigate your …
Considerations to maximise 6CPA programs
Now that more funding for 6CPA programs is available, it’s time to leverage it, writes Stephenie Shea MedsChecks and Diabetes Medschecks are an important service offered by pharmacies. They aim …
A debased prescription for change
King Review interim report findings won’t pass the test of public scrutiny, argues Dr Rohan Miller An interim report titled Review of pharmacy remuneration and regulation was quietly published recently which …
Managing minor ailments: a global snapshot
What do Minor Ailments Schemes look like in practice internationally? Dr. Angel Gonzalez investigates The pharmacy profession has aimed to transition from a distributive focus to a patient-centric care focus …
The question of deregulation
What might happen if supermarkets enter the pharmacy industry? asks Michael Rhodes Much debate has arisen about what happens next in the pharmacy industry and regrettably, some think the current …
Clinical Intervention: a clinical or financial scheme?
This week’s contributor wanted to remain anonymous: here, our Guest Author asks whether the Clinical Intervention scheme should exist in its current form at all A brief overview Let’s begin …
Guild pens open letter on codeine
Here is a list of ways the Pharmacy Guild has worked on the codeine issue, explains Executive Director David Quilty Dear AJP readers I must say that I find it …
Does anyone have HMR pharmacists’ back?
Failure to lift the cap on HMRs makes no sense, writes Karalyn Huxhagen The recent discussion about the new Community Pharmacy Agreement rules has fuelled my ire. When I spoke …